Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$12,009,479
+$67,608 QoQ
Shares Held
47,287
-3.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.48%
of 13F equity value
Holder Rank
#999
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keystone Financial Group holds $28,513,517 across 12 Drug Manufacturers - General names. JNJ ranks #1 (42.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
47,287 | $12,009,479 | |
| 2 | LLY |
ELI LILLY & Co
|
4,531 | $5,434,617 | |
| 3 | ABBV |
AbbVie Inc.
|
14,346 | $3,610,027 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,960 | $2,564,860 | |
| 5 | PFE |
Pfizer Inc
|
80,610 | $1,941,088 | |
| 6 | AMGN |
Amgen Inc
|
2,034 | $736,552 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,142 | $523,300 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,578 | $494,264 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,009,479 | 47,287 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $11,941,871 | 48,854 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,939,601 | 48,029 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $9,531,515 | 51,405 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $7,129,148 | 46,672 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,434,275 | 44,828 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,293,428 | 43,517 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,172,720 | 25,748 | Shares | Sole | 2025-02-19 | |
| 2024-06-30 | $3,627,106 | 24,816 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $3,767,611 | 23,817 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,739,032 | 23,855 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,100,897 | 26,330 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $4,660,050 | 28,154 | Shares | Sole | 2023-08-07 | |
| 2022-12-31 | $4,944,610 | 27,991 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $4,784,651 | 29,289 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,994,776 | 28,138 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $4,971,833 | 28,053 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,719,479 | 27,588 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,607,272 | 28,528 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,814,526 | 29,225 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,785,872 | 29,120 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $4,593,922 | 29,190 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,291,763 | 28,827 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,943,827 | 28,044 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,588,372 | 27,365 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||